HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 47 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,258,658 | -41.3% | 5,047,000 | -42.2% | 0.01% | -45.5% |
| Q2 2023 | $7,254,998 | -4.3% | 8,735,000 | -2.4% | 0.01% | -8.3% |
| Q1 2023 | $7,581,796 | -10.7% | 8,946,000 | +2.1% | 0.01% | -20.0% |
| Q4 2022 | $8,486,583 | +2.7% | 8,766,000 | -10.3% | 0.02% | -6.2% |
| Q3 2022 | $8,266,000 | -0.6% | 9,768,000 | +3.6% | 0.02% | +6.7% |
| Q2 2022 | $8,319,000 | +3.7% | 9,430,000 | +2.4% | 0.02% | +25.0% |
| Q1 2022 | $8,026,000 | – | 9,212,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 128,679,626 | $110,468,006 | 5.49% |
| CAMDEN ASSET MANAGEMENT L P /CA | 77,223,000 | $65,160,767 | 2.42% |
| Penn Mutual Asset Management | 1,555,000 | $1,312,109 | 1.23% |
| ZAZOVE ASSOCIATES LLC | 9,108,000 | $7,715,000 | 0.80% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 50,000,000 | $42,190,000 | 0.67% |
| LAFFER TENGLER INVESTMENTS, INC. | 2,399 | $2,032,823 | 0.60% |
| SHENKMAN CAPITAL MANAGEMENT INC | 9,019,000 | $7,767,672 | 0.58% |
| LINDEN ADVISORS LP | 62,930,000 | $53,329,425 | 0.55% |
| SSI INVESTMENT MANAGEMENT LLC | 4,577,000 | $3,862,074 | 0.32% |
| Sonora Investment Management Group, LLC | 4,355,000 | $3,675,060 | 0.31% |